Published 2016
| Version v1
Publication
Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody
Additional details
- URL
- http://hdl.handle.net/11567/848543
- URN
- urn:oai:iris.unige.it:11567/848543
- Origin repository
- UNIGE